NCT07847086

Brief Summary

This cross-sectional study aims to assess the pattern of gait in patients with multiple sclerosis and to evaluate its relation to cognitive function, visual evoked potentials, and radiological findings.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
17mo left

Started Sep 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Mar 2028

First Submitted

Initial submission to the registry

September 23, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

September 26, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 23, 2026

Last Update Submit

September 28, 2026

Conditions

Keywords

Visual evoked potentialsMultiple sclerosisGait analysisCognitionAssiut

Outcome Measures

Primary Outcomes (1)

  • Mean gait velocity

    Mean gait velocity in meters per second measured by quantitative spatiotemporal gait analysis.

    Baseline

Secondary Outcomes (5)

  • Mean cadence

    Baseline

  • Mean stride length

    Baseline

  • Mean MoCA score

    Baseline

  • Mean P100 latency

    Baseline

  • Mean EDSS score

    Baseline

Study Arms (1)

Single cohort: Multiple Sclerosis Patients

Patients with confirmed multiple sclerosis who will undergo gait analysis, cognitive testing, visual evoked potential assessment, and MRI review in a single visit.

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients with multiple sclerosis attending the Neurology Department outpatient clinic and gait laboratory at Assiut University.

You may qualify if:

  • \- Age 18 to 55 years
  • Confirmed diagnosis of multiple sclerosis according to the revised McDonald criteria
  • Clinically stable (no relapse or steroid treatment within 4 weeks)
  • Able to walk independently with or without a single assistive device
  • Written informed consent

You may not qualify if:

  • \- Other neurological, orthopedic, visual, or vestibular conditions affecting gait
  • Severe cognitive impairment precluding valid testing
  • Pregnancy
  • MRI contraindications
  • Ocular disease unrelated to multiple sclerosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Multiple SclerosisGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Tarek A Rageh, prof

    Neuropsychiatry Department, Assiut University Hospitals

    STUDY CHAIR

Central Study Contacts

Manar A Ali, Resident

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Department of Neuropsychiatry

Study Record Dates

First Submitted

September 23, 2026

First Posted

September 29, 2026

Study Start

September 26, 2026

Primary Completion (Estimated)

September 26, 2027

Study Completion (Estimated)

March 1, 2028

Last Updated

October 1, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share